Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone as an adjuvant to bupivacaine in intrapleural infiltration after thoracic surgery
PACTR201805003370384Not yet recruiting
- Sponsor
- Tanta University Hospitals
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of naloxone and bupivacaine in postoperative pain (2 arms), sponsored by Tanta University Hospitals. Primary endpoint: Time to first request for rescue analgesia. Planned start May 2018; status: not yet recruiting.
02
Drugs
naloxonebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR201805003370384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201805003370384.